Toggle navigation
About
Approach
Team
Companies
News Room
Contact
Medicxi announces the closing of its first €200 million Secondary Fund, led by Pantheon with co-lead LGT Capital Partners
Press Release
Operation Warp Speed – Moncef Slaoui’s mission to deliver a COVID-19 vaccine
Blog
First subject dosed with ZF874, a potential disease-modifying treatment for alpha-1-antitrypsin deficiency
Press Release
Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters
Press Release
ApcinteX Starts Clinical Trial of Novel Haemophilia Drug
Press Release
